Pre-operative blood donation: A Saudi experience

Saudi Medical Journal

Volumn 20, Issue 2, 1999, Pages 162-166

  Al Momen, Abdulkareem M ^a   Al Qasabi, Qasim O ^b  

^a Division of Gynecologic Oncology   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Erythropoietin; Iron polymaltose; Personal pre operative blood donation; Preoperative autologous blood donation

Indexed keywords

EID: 0009511525     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Davenport RD. Hemolytic Transfusion Reactions. In: Popovsky MA, ed. Transfusion Reactions: AABB press, Bethesda 1996: 1-44.
2. Heddle NM, Kelton JG. Febrile Nonhemolytic Transfusion Reactions. In: Popovsky MA, ed. Transfusion Reactions: AABB Press, Bethesda 1996: 45-80.
3. Vamvakas EC, Pineda AA. Allergic and Anaphylactic Reactions. In: Popovsky MA, ed. Transfusion Reactions: AABB Press, Bethesda 1996: 81-123.
4. AuBuchon JP, Kruskall MS. Transfusion safety: realigning efforts with risks. Transfusion 1997; 37: 1211-1216.
5. Smith DM, Dodd RY, eds. Transfusion Transmitted Infections. ASCP Press. Chicago 1991; 1-314.
6. Menitove JE. How Safe is Blood Transfusion?. In: Dennis & Dodd, eds. Transfusion-Transmitted Infections. ASCP press. Chicago 1991; 1-21.
7. Alexander JW. Transfusion induced immunomodulation and infection. Transfusion 1991; 31: 195-196.
8. Triluzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologie study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992; 32: 517-524.
9. Heiss MM, Mempel W, Delanoff CH, Jauch KW et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867.
10. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. BrJSurg 1993; 80: 427-432.
11. Vamkas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis. Transfusion 1993; 33:754.
12. Vamvakas EC, Carven JH. Transfusion of white-cellcontaining allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfusion Medicine 1998; 8: 29-36.
13. Duggy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfusion Medicine 1996; 6: 325-328.
14. Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications: A review. Transfusion 1994;34:714-727.
15. Heis MM, Mempel W, Jauch K, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer Surgery. Lancet 1993; 342: 13281333.
16. Singh SK, Marquet RL, Westbroike Dl, Jeekel J. Enhanced growth of artificial tumor métastases following blood transfusion: The effect of erythrocytes, leukocytes and plasma transfusion. Eur J Cancer Clin Oncol 1987; 23: 1537-1540.
17. Popovsky MA. Transfusion-related acute lung Injury (TRALI). In: Popovsky MA, ed. Transfusion Reactions: AABB Press, Bethesda 1996: 167-183.
18. Philipps E, Fleischener FG. Pulmonary edema in the course of a blood transfusion without overloading the circulation. Dis Chest 1966; 2: 242-248.
19. Popovsky MA, Chaplin HC JR, Moore SB. Transfusionrelated acute luns injury: A neglected, serious complication of chemotherapy. Transfusion 1992; 32: 589-592.
20. lain J. Webb, Kenneth C. Anderson. Transfusion-Associated Graft-vs-Host Disease. In: Popovsky MA, ed. Transfusion Reactions: AABB Press, Bethesda 1996: 185-204.
21. Hathaway WE, Fulginiti VA, Pierce CW et al. Graft-vs-host reaction following a single blood transfusion. JAMA 1967; 201: 1015-1020.
22. Shivdasani RA, Anderson KC. Transfusion-associated graflversus-host disease: Scratching the surface. Transfusion 1993; 33: 696-697.
23. O'Connor NTJ, Mackintosh P. Transfusion associated graft versus host disease in an immunocompetent patient. J Clin Pathol 1992; 45: 621-622.
24. Beal RW. Alternatives to Allogenic Blood Transfusion. Vox Sang 1994; 76(Suppl 5): 62-64.
25. Global Blood Safety Initiative: Autologous Transfusion in Developing Countries. WHO/GPA/INF/91.9, WHO/LBS/ 91.2. Geneva, World Health Organization 1990.
26. Pearl Toy. Pre-operative autologous blood donation. In: Rossi EC, Simon RL, Moss GS, eds. Principles of Transfusion Medicine. Williams & Wilkins: Baltimore 1991; 401-404.
27. Royal College of Physicians of Edinburgh Consensus Conference on Autologous Transfusion. Edinburgh, 4-6 October 1995. Transfusion 1996; 36: 625-667.
28. National Heart, Lung and Blood Institute Expert Panel on the use of Autologous Blood. Transfusion alert: Use of autologous blood. Transfusion 1995; 35: 703-711.
29. Council of Europe: Guidelines for Autologous Blood Transfusion: A consensus Opinion of the Committee of Experts on Blood Transfusion and Immuno-hematology. Vox Sang 1989; 57: 278-280.
30. British Committee for Standards in Haematology Blood Transfusion Task Force: Guidelines for autologous donation: Preoperative autologous donation. Transfus Med 1993; 3: 307-316.
31. Goodnough LT, Monk TG, Brecher ME. Autologous Blood Procurement in the Surgical Setting: Lessons Learned in the Last 10 years. Vox Sang 1996; 71: 133-141.
32. Pinkerton PH. Two years' experience with a Canadian hospital-based autologous blood donor programme. Transfusion Medicine 1994; 4: 231-236.
33. Pinkerton PH. Use of autologous blood in support of orthopaedic surgery using a hospital-based autologous donor programme. Transfusion Medicine 1995; 5: 139-144.
34. Pinkerton PH, Governs A. Autologous blood transfusion in radical hysterectomy. Transfusion Medicine 1996; 6: 223225.
35. Toy PTCY, Menozzi D, Strauss RG, Stehling LC, Kruskall M, Ahn DK. Efficacy of preoperative donation of blood for autologous use in radical prostatectomy. Transfusion 1993; 33: 721-724.
36. Renner SW, Howanitz PJ, Bachner P. Pre-operative autologous blood donation in 612 hospitals. A college of American Pathologist's Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1992; 116: 613619.
37. Napier JAF, Boulton FE, Cann R et. al. Guidelines for implementation of a maximum surgical blood order schedule. Clin. lab. Haemal. 1990; 12: 321-327.
38. Friedman BA, Oberman HA, Chadwick AR, Kingdon K.I. The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 1976; 16: 380387.
39. Perrault RA, Barr RA. Blood ordering strategies. In: Cash JD ed. Progress in Transfusion Medicine. Churchill Livingstone, Edinburgh 1986; 95-107.
40. Mayer MN, de Montalember M, Audat F, Brüssel MC, et al. Aulologous Blood Donalion for Eleclive Surgery in Children Weighing 8-25kg. Vox Sang 1996; 70: 224-228.
41. Mayer MN, Goujard E, Audat F, Brüssel MC, Barrier G: Autolosous blood transfusion in children weishing less than 25kg. Pediatr Anesth 1994; 4: 343-345.
42. Simpson MB, Georgopoulos G, Orsini E, Eilert. RE: Autolosous transfusions for orthopaedic procedures at a children's hospital. J. Bone Joint Surg 1992; 74-A: 652-658.
43. Tasaki T, Ohio H, Noruchi M, Abe R, Kikuchi S, Hoshino S: Autoloaous blood donation elective surgery in children. Vox Sang 1994; 66: 188-193.
44. Silvergleid AJ: Safety and effectiveness of predoposit autologous transfusions in preteen and adolescent children. JAMA 1987; 257: 3403-3404.
45. Novak RW: Autologous blood transfusion in a pédiatrie population: Safety and efficacy. Clin Pediatr 1988; 27: 184187.
46. McEwen GD, Bennett E, Guille JT: Autologous blood transfusions in children and young adults with low body weieht undergoing spinal surcery. Jpediatr orthop 1990; 10: 750-753.
47. Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, Tuman KJ, Ivankovich AD. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion 1992; 32(1): 17-22.
48. Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987; 43: 508-512.
49. Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially "high-risk" patients. Transfusion 1983; 23: 229232.
50. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989; 262: 1963-1968.
51. Pindyck J, Avorn J, Kuriyan M, Reed M, Iqbal MJ, Levine SJ. Blood donation by the elderly. Clinical and policy considerations. JAMA 1987; 257: 1186-1188.
52. Sammarco MJ, Slate WG, Wapner R, Komins JI, Egan JJ. Autolosous blood donation during preanancy. Del Med J 1987; 59: 661-665.
53. Combs CA, Murphy El, Laros RK: Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 1992; 80: 621-625.
54. Langstaff RJ et al. Treatment of iron-deficiency anemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate. Brit. Res. 1993:4:191-198.
55. Muller A. Classification and properties of iron preparations. Arzneim. Forsch./(Drug Research), 1974; 24: 880-883.
56. Geisser P. In vitro studies on interactions of iron salts and complexes with foodstuffs and medicaments. ArzneimittelForschung/Drug Research 40(11), Mr. 1990; 7: 754-760.
57. Forth W. Iron - Unavailability, Absorption, Utilization, BlWiss. verl. 1993; 51-55.
58. Ereth MH, Oliver WC Jr, Santrach PJ. Perioperative interventions to decrease transfusion of allogeneic blood products. Mayo Clin Proc 1994; 69: 575-586.
59. Popovsky MA. Autolocous blood transfusion in the 1990s. Where is it heading? (editorial). AM J Clin Pathol 1992; 97: 297-300.
60. Biesma DH, Marx JM, Kraaijenhagen RJ, Werner Franke, Diethelm Messigner, Albert van de Wiel. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. The Lancet 1994; 344 (8919): 367-370.
61. Brugnara C, Chambers LA, Malynn E et al. Red blood cell regeneration induced by subcutaneous recombinant erytopoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993; 81: 956-964.
62. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33: 5560.
63. Messmer K, ed. Proceedings of the roundtable of experts in surgery blood manacement: Vienna, April 9, 1995. Semin Hematol 1996; 33(2 Suppl 2): 1-80.
64. Biesma DH, Kraaijenhagen RJ, Poortman J et al. The effect of oral iron supplementation on erythropoiesis in autolosous blood donors. Transfusion 1992; 32: 162-165.
65. Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially high risk patients. Transfusion 1983; 23: 229232.
66. Technical Manual Committee. Autologous Blood collection and Transfusion. In: Virginia Vengelen-Tyler, Kaaron Benson, Donald R. Branch et al. eds. Technical Manual 12th. ed Bethesda, AABB Press 1996; 103-114.
67. Global Blood Safety Initiative: Autolosous transfusion in developing countries. WHO/GPA/INF/91.1, WHO/LBS/ 91.2. Geneva, Word Health Organization, 1990.
68. Ennio C. Rossi, Toby L. Simon, Gerald S. Moss, eds. Principles of Transfusion Medicine. Baltimore: Williams & Wilkins: 1991; 561-659.
69. Pearl Toy. Preoperative Autologous Blood Donation. In: Ennio C. Rossi, Toby L. Simon, Gerald S. Moss, eds. Principles of Transfusion Medicine. Baltimore: Williams & Wilkins; 1991: 401-404.